Figure 1From: Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study Median absolute change in burden of disease (BOD) in each treatment group. IFN, interferon; im, intramuscular; qw, once weekly; sc, subcutaneous; tiw, three times weekly.Back to article page